Ne
Non verificato

NeuraLight

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieSaluteTecnica
13/08/2026
Industria
Software
Scienza
Vetrine/Shopping
Tecnica
Medicina - Varie
Biotecnologia
Terza età
Salute
Landmark International Brain Health Initiative Deploys NeuraLight's Biomarkers to Quantify Change in Brain Function
1.00
05/08/2026
Industria
Salute
Tecnica
Medicina - Varie
Biotecnologia
Clinical Trial Results Show NeuraLight Biomarkers Predict Functional Decline in People With Parkinson’s Disease
1.00
14/07/2026
Eventi
Tecnica
Medicina - Varie
Software
Biotecnologia
Farmaceutica
Salute
NeuraLight Wins Fast Company’s World Changing Ideas Award for Its Innovation in Brain Function Measurement
1.00
03/06/2026
Tecnica
Libri/Editoria
Medicina - Varie
Comunicazione
Biotecnologia
Sanità
Salute
Information Technology
Industria
NeuraLight Biomarkers Reveal What Parkinson's Gold-Standard Measurement Scale Misses in a Study Led by the Scale's Own Developers
1.00
14/05/2026
Mercato del lavoro
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Kariya and NeuraLight Partner to Measure How Next-Generation GLP-1 Therapies Impact the Brain
1.00
26/02/2026
Industria
Information Technology
Biotecnologia
Tecnica
Sanità
Salute
Tecnologie Varie
Medicina - Varie
NeuraLight at AD/PD 2026: Revealing Next-Generation Brain-Function Biomarker Readouts Powering a First-of-its-Kind Neuroprotection Signal in Drug Trials
1.00
21/01/2026
Software
Scienza
Farmaceutica
Psichiatria
Tecnica
Biotecnologia
Medicina - Varie
Salute
Mercato del lavoro
Industria
NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial
1.00
07/01/2026
Tecnica
Scienza
Medicina - Varie
Software
Biotecnologia
Salute
Farmaceutica
Industria
NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial
1.00
07/01/2026
Industria
Tecnica
Scienza
Medicina - Varie
Software
Biotecnologia
Salute
Farmaceutica
NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0